VRK1 inhibitor therapy(Evariste Technologies)

N/A

Report date: 2024/12/27 15:40:59
NME

Base Information

Drug NameVRK1 inhibitor therapy(Evariste Technologies)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVRK Serine/Threonine Kinase 1 inhibitors
TargetsVRK Serine/Threonine Kinase 1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvariste Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEvariste Technologies Ltd
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A